Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Mar 22, 2021
Open Peer Review Period: Mar 22, 2021 - May 17, 2021
Date Accepted: Apr 28, 2022
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Development, Testing, and Implementation of the Belgian Patient Reported Experience Measure for Pancreatic Cancer Care (PREPARE) Project: Protocol for a Multi-Method Research Project

Moens K, Peeters M, Van den Bulcke M, Leys M, Horlait M

Development, Testing, and Implementation of the Belgian Patient Reported Experience Measure for Pancreatic Cancer Care (PREPARE) Project: Protocol for a Multi-Method Research Project

JMIR Res Protoc 2022;11(6):e29004

DOI: 10.2196/29004

PMID: 35666559

PMCID: 9210207

The development, testing and implementation of a Belgian Patient REported experience measure for PAncrREatic cancer care (PREPARE) project. Protocol of a Multi-Method research project

  • Katrien Moens; 
  • Marc Peeters; 
  • Marc Van den Bulcke; 
  • Mark Leys; 
  • Melissa Horlait

ABSTRACT

Background:

Pancreatic cancer patients do not feel involved in the development of their treatment and care plans. In Belgium these plans are decided on during multidisciplinary team meetings. However, limited time is spent on the discussion of the preferences of the patient during these meetings. This research project wants to develop a Patient Reported Experience Measure (PREM) for pancreatic cancer and assess if its use can support collaborative treatment decision making.

Objective:

This article aims to outline the protocol for a multi-method research project to improve person-centered pancreatic cancer care in Belgium. Three sub-objectives are pursued: to develop a PREM measuring the experiences of care-related aspects in pancreatic cancer care; to validate the PREM, and to develop and evaluate an (educational) intervention to support the use of the PREM results.

Methods:

For the development of the PREM an exploratory mixed-methods study design will be used. The study will start with a survey followed by a telephone interview involving pancreatic cancer patients and digestive oncology health care professionals. Study two is the testing of the content and construct validity of the PREM. Study three involves the implementation study according to the MRC framework of a complex intervention introducing the PREM in practice. The effectiveness of the intervention will be investigated using a Pragmatic Randomized Controlled Trial (PrCT) study design.

Results:

The protocol presents the entire structure of the research project. The results of each study are necessary to conduct the following study.

Conclusions:

The poor prognosis of pancreatic cancer patients should not be considered as a hurdle to not study this patient population group. Involving patients in the research and decision-making processes early on is key. This project aims to realize a scientifically sound research process providing research outputs that can easily and timely be implemented in the care trajectory of pancreatic cancer patients. This research project will also lead to recommendations on how to involve pancreatic cancer patients and how the methodology of this research project can be translated to other patient groups.


 Citation

Please cite as:

Moens K, Peeters M, Van den Bulcke M, Leys M, Horlait M

Development, Testing, and Implementation of the Belgian Patient Reported Experience Measure for Pancreatic Cancer Care (PREPARE) Project: Protocol for a Multi-Method Research Project

JMIR Res Protoc 2022;11(6):e29004

DOI: 10.2196/29004

PMID: 35666559

PMCID: 9210207

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.